Insulet Corp. deserves a worldwide permanent injunction against EOFlow Co. Ltd., but its $452 million insulin pump patch trade secrets verdict must be dramatically reduced to $59.4 million, a federal judge ruled Thursday.
The US District Court for the District of Massachusetts ruled that awarding future damages and an injunction would be improper double-recovery. Insulet opted to seek the injunction plus past-based damages rather than the full award, the court said, noting the trial established EOFlow had approximately $24 million in net assets “at most.”
US District Judge Dennis Saylor IV’s opinion noted EOFlow’s inability to pay the original verdict ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.